PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.34 - 0.34
0.23 - 0.41
110.0K / 51.2K (Avg.)
-1.33 | -0.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-19.39%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-7.05%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
No Data
No Data available this quarter, please select a different quarter.
-49.95%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-11.57%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-10.80%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-10.80%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-0.83%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.83%
Reduced diluted shares while 0458.HK is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-125.46%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-125.55%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-64.23%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-63.34%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-63.63%
Negative 3Y CAGR while 0458.HK stands at 44.30%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-231.27%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-246.17%
Negative 5Y OCF/share CAGR while 0458.HK is at 59.53%. Joel Greenblatt would question the firm’s operational model or cost structure.
49.50%
3Y OCF/share CAGR 1.25-1.5x 0458.HK's 35.80%. Bruce Berkowitz might see if strategic cost controls or product mix drove recent gains.
-77.53%
Negative 10Y net income/share CAGR while 0458.HK is at 33.29%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-41.50%
Negative 5Y net income/share CAGR while 0458.HK is 55.96%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-51.85%
Negative 3Y CAGR while 0458.HK is 66.29%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
2.52%
Positive 5Y equity/share CAGR while 0458.HK is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
-1.93%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
-51.20%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
-15.61%
Negative near-term dividend growth while 0458.HK invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
2.61%
AR growth is negative/stable vs. 0458.HK's 15.02%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
-13.49%
Inventory is declining while 0458.HK stands at 45.30%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-11.95%
Negative asset growth while 0458.HK invests at 13.76%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
1.49%
Under 50% of 0458.HK's 34.44%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-60.19%
We’re deleveraging while 0458.HK stands at 739.61%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-100.00%
Our R&D shrinks while 0458.HK invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-18.87%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.